Fortis Healthcare Ltd
Fortis Healthcare Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Fortis Healthcare expects continued growth in both revenue and operational scale over the next 2 years, driven by: - Addition of approximately 430 beds in FY '27, with most becoming operational except phased expansion at FMRI. Fortis Healthcare expects continued revenue growth at least for the next 2 years, supported by brownfield expansions, especially at premier facilities like FMRI (Page 10).
From Fortis Healthcare Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Fortis Healthcare expects continued growth in both revenue and operational scale over the next 2 years, driven by:
- Addition of approximately 430 beds in FY '27, with most becoming operational except phased expansion at FMRI.
- Brownfield expansions in key units like FMRI, Jalandhar, TMI, Greater Noida, and Shalimar Bagh, enhancing capacity and improving margins.
- Stabilization and ramp-up at newly acquired and expanding units such as People Tree (Bangalore), Manesar, and Gleneagles (Hyderabad and Bangalore).
- ARPOB (Average Revenue Per Occupied Bed) anticipated to grow at 4-5% annually due to favorable product mix and moderate price increases.
- Continued growth supported by diagnostic business expansion, increasing preventive and specialized test portfolios.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Fortis Healthcare Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Brownfield expansions approved/planned:
- Onco block in Faridabad unit approved by Board.
- Expansion in Jalandhar and TMI units using adjacent land parcels.
- Greater Noida to increase capacity from 150 to 250-300 beds.
- Planning expansion at Shalimar Bagh (approval secured).
- FMRI's flagship hospital expansion delayed, targeted by April.
- New projects under consideration at Mohali, Shalimar Bagh.
- People Tree acquisition in Bangalore (125 beds) being expanded to 300 beds with related capex for medical equipment and civil infrastructure estimated around INR800 crores—cheaper than greenfield INR1,000 crores for similar capacity.
- Capital infusion expected from IHH (post open offer cooling period ending May), likely via preferential allotment, to support growth and reduce debt.
2 more points management made on capital expenditure plans
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Fortis Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Fortis Healthcare Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.4K Cr, net profit ₹271 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Fortis Health.'s management said in earlier quarters
Others in Healthcare Services this season
- Vijaya Diagnost. (Q3 FY26)
FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnost.'s Q3 FY26 earnings call — and…
- Aster DM Quality (Q3 FY26)
Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…
- Chandan Healthcare Ltd (Q3 FY26)
The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…
- Rainbow Child. (Q3 FY26)
Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…
Frequently Asked Questions
What were Fortis Healthcare Ltd Q3 FY26 results?
Fortis Healthcare expects continued growth in both revenue and operational scale over the next 2 years, driven by: - Addition of approximately 430 beds in FY '27, with most becoming operational except phased expansion at FMRI. Fortis Healthcare expects continued revenue growth at least for the next 2 years, supported by brownfield expansions, especially at premier facilities like FMRI (Page 10).
What is Fortis Healthcare Ltd share price analysis?
Fortis Healthcare Ltd currently shows a neutral. The stock trades at a P/E of 66.1 with a market cap of ₹69,834 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fortis Healthcare Ltd planning capital expenditure?
Brownfield expansions approved/planned: - Onco block in Faridabad unit approved by Board.
Keep Fortis Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.